Rare opportunity to acquire a thriving, single-specialty endocrinology practice on Florida’s Gulf Coast — one of the most sought-after communities in the United States to live and practice medicine. Founded in 1998 and led by a FACE-credentialed endocrinologist with 40+ years of experience, this practice has delivered full-scope specialist care continuously for 28 years, building a loyal patient base and deep referral network that a new owner inherits on day one.
Full-scope outpatient endocrinology including diabetes, thyroid/parathyroid, osteoporosis, adrenal/pituitary, HRT, insulin pump therapy, CGM management, in-office thyroid ultrasound, and FNA. First-floor suite in a professionally managed Gulf Coast medical complex. Owner-occupied medical condo available for lease or purchase.
PRACTICE METRICS
- 3,500 established patient visits annually
- 260 new patients accepted in 2025
- 420 thyroid ultrasounds | 71 FNA procedures annually
- 725 CGM placements & interpretations annually
- Providers: 1 MD (FACE) + 1 NP | EMR: AdvancedMD (since 2014)
- Hours: Mon–Thu 9am–4:30pm | Fri 9am–noon
FINANCIALS — Revenue / SDE
- 2025: $502,877 / $128,073 (25% margin)
- 2024: $517,645 / $165,839 (32% margin)
- 2023: $560,926 / $186,382 (33% margin)
- 2022: $528,680 / $182,493 (35% margin)
Revenue reflects deliberate schedule wind-down ahead of retirement — not a demand issue. A buyer restoring full capacity steps into a proven platform with immediate upside.
PAYER MIX: Medicare 60–70% | Commercial 30–40%
DEAL STRUCTURE: $295,000 asking. $265,000 cash at close + $30,000 seller carry to qualified physician buyer. Min. EMD: $25,000. A/R excluded. Condo lease or purchase negotiated separately.
THIS PRACTICE IS IDEAL FOR:
- Employed endocrinologist seeking independence in a premier Gulf Coast market
- Endocrinology group adding a satellite in a high-demand, underserved region
- Primary care or multispecialty group absorbing an established endocrine panel with trained staff in place
- Value-based care organization (ACO/MSSP/capitated) bringing endocrinology in-house to reduce diabetes costs, close referral loops, and improve shared savings performance
Confidential — practice identity disclosed after NDA execution.
In Association with ParaSell, Inc. | A Licensed Florida Broker
